These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28578552)

  • 1. Pharmacokinetic/Pharmacodynamics-Optimized Antimicrobial Therapy in Patients with Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia.
    Sulaiman H; Abdul-Aziz MH; Roberts JA
    Semin Respir Crit Care Med; 2017 Jun; 38(3):271-286. PubMed ID: 28578552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized antibiotic strategies.
    Taccone FS; Bond O; Cavicchi FZ; Hites M
    Curr Opin Anaesthesiol; 2016 Apr; 29(2):166-71. PubMed ID: 26765979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing antibiotic pharmacodynamics in hospital-acquired and ventilator-acquired bacterial pneumonia.
    Housman ST; Kuti JL; Nicolau DP
    Clin Chest Med; 2011 Sep; 32(3):439-50. PubMed ID: 21867814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations.
    Torres A; Mouton JW; Pea F
    Clin Pharmacokinet; 2016 Dec; 55(12):1507-1520. PubMed ID: 27272266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia.
    Wood GC
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):993-1000. PubMed ID: 22029519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance.
    Udy AA; Roberts JA; De Waele JJ; Paterson DL; Lipman J
    Int J Antimicrob Agents; 2012 Jun; 39(6):455-7. PubMed ID: 22483562
    [No Abstract]   [Full Text] [Related]  

  • 8. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies and Evolving Concepts in Hospital-Acquired Pneumonia.
    Chastre J; Luyt CE
    Semin Respir Crit Care Med; 2017 Jun; 38(3):235-236. PubMed ID: 28578547
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic/Pharmacodynamic Optimization of Hospital-Acquired and Ventilator-Associated Pneumonia: Challenges and Strategies.
    Abouelhassan YP; Nicolau D
    Semin Respir Crit Care Med; 2022 Apr; 43(2):175-182. PubMed ID: 35088402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
    Barbier F; Andremont A; Wolff M; Bouadma L
    Curr Opin Pulm Med; 2013 May; 19(3):216-28. PubMed ID: 23524477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Empiric de-escalation strategy of antibiotic treatment].
    Adukauskiene D; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(9):703-8. PubMed ID: 17028467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
    Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit.
    Becher RD; Hoth JJ; Rebo JJ; Kendall JL; Miller PR
    Surg Infect (Larchmt); 2012 Dec; 13(6):352-9. PubMed ID: 23268613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing Antibiotic Administration for Pneumonia.
    Motos A; Kidd JM; Nicolau DP
    Clin Chest Med; 2018 Dec; 39(4):837-852. PubMed ID: 30390753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for hospital-acquired pneumonia.
    Liapikou A; Rosales-Mayor E; Torres A
    Expert Opin Pharmacother; 2014 Apr; 15(6):775-86. PubMed ID: 24579912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the clinical pulmonary infection score impact ICU antibiotic days?
    Swoboda SM; Dixon T; Lipsett PA
    Surg Infect (Larchmt); 2006 Aug; 7(4):331-9. PubMed ID: 16978076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update.
    Abu-Salah T; Dhand R
    Adv Ther; 2011 Sep; 28(9):728-47. PubMed ID: 21833701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.